Skip to main content
. 2013 Sep 23;2013:604301. doi: 10.1155/2013/604301

Figure 2.

Figure 2

Patient 4. (a) A facial basal cell carcinoma appeared after six months of everolimus treatment. (b) The lesion had disappeared after a further nine months of treatment (3 mg daily).

HHS Vulnerability Disclosure